国内中西医结合病房的药物治疗相关问题研究

doi:10.5246/jcps.2022.04.025

中国药学(英文版) ›› 2022, Vol. 31 ›› Issue (4): 279-288.DOI: 10.5246/jcps.2022.04.025

• 【药事管理与临床药学专栏】 • 上一篇下一篇

国内中西医结合病房的药物治疗相关问题研究

杨杰¹^,^*(), 孟海阳¹, 李朵璐¹, 王艳英², 古兆森³, 张晓坚¹

1. 郑州大学第一附属医院药学部, 河南郑州 450052
2. 河南大学第一附属医院药学部, 河南开封 475000
3. 郑州大学第一附属医院中西医结合科, 河南郑州 450052

收稿日期:2021-12-04 修回日期:2021-12-27 接受日期:2022-01-24 出版日期:2022-04-30 发布日期:2022-04-30
通讯作者: 杨杰
作者简介:
+ Tel.: +86-15981892331, E-mail: jiebridges@126.com
基金资助:
National Major New Drug Creation Project of China (Grant No. 2020ZX09201-009).

Drug-related problems among inpatients of integrated traditional Chinese and western medicine department in China

Jie Yang¹^,^*(), Haiyang Meng¹, Duolu Li¹, Yanying Wang², Zhaosen Gu³, Xiaojian Zhang¹

1 Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China
2 Department of Pharmacy, the First Affiliated Hospital of Henan University, Kaifeng 475000, Henan, China
3 Department of Traditional Chinese Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China

Received:2021-12-04 Revised:2021-12-27 Accepted:2022-01-24 Online:2022-04-30 Published:2022-04-30
Contact: Jie Yang

摘要/Abstract

摘要：

对中西医结合病房住院患者开展药物治疗相关问题的研究具有挑战性, 我们希望明确此类患者的药物治疗相关问题发生情况及其影响因素。回顾性分析我院中西医结合病房相关资料, 以欧洲药学监护联盟分类工具V9.0, 对药物治疗问题进行确证和分类, 并开展相关性分析。研究共纳入1606名患者, 其中至少出现1种药物治疗相关问题的人数约占一半(47.6%)。问题主要来源于PPI (21.7%), 内源性补充剂 (15.4%) 和中药制剂 (8.7%)等。最常见的原因类别包括"给药途径错误"(18.4%)、"不适当联合用药"(16.7%)、"疗程过长"(13.0%) 和"选择了不适当的用药剂型"(12.1%)。约63.6%的干预措施被接受和实施。出现问题最可能的相关因素是"过度联用药物"和"住院时间≥10天"。中西医结合病房药物治疗相关问题的存在较为普遍, 在我们提供的策略基础上有必要开展进一步研究。

关键词: 药物治疗相关问题, DRPs, 中西医结合病房, ITCWM

Abstract:

It is challenging to characterize the drug-related problems (DRPs) of patients treated by Integrated Traditional Chinese and Western Medicine (ITCWM), both locally and globally. In the present study, we aimed to assess DRPs and factors associated with their occurrence among inpatients of the ITCWM department in China. We retrospectively examined medication use in the ITCWM department, documented in Intelligent Management System Software for Critical Rational Administration of Drug. Various types of DRPs classification were performed based on the Pharmaceutical Care Network Europe (PCNE) classification tool V9.0, and associations of patient’s characteristics were analyzed. A total of 1606 DRPs were identified in 687 inpatients in this study. Problems and causes of DRPs, intervention, acceptance, and outcome of that were classified. PPI (21.7%), endogenous supplements (15.4%), and traditional Chinese medicine (8.7%) contributed to the significant proportion of drug categories associated with DRPs. Approximately half of the patients (47.6%) had at least one DRP. The top four categories of causes were "drug administered via the wrong route" (18.4%), "inappropriate combination" (16.7%), "too long duration of the treatment" (13.0%), and "inappropriate drug form" (12.1%). Total 63.6% of intervention was accepted and fully implemented. "EPP" and "hospital stay days ≥ 10 d" characteristics were most likely to be significantly associated with DRPs. As a necessary review item, DRP was highly performed among inpatients of the ITCWM department. The work provided a benchmark for this population through the PCNE strategy.

Key words: Drug-related problems, DRPs, Integrated traditional Chinese and western medicine department, ITCWM

Supporting:

杨杰, 孟海阳, 李朵璐, 王艳英, 古兆森, 张晓坚. 国内中西医结合病房的药物治疗相关问题研究[J]. 中国药学(英文版), 2022, 31(4): 279-288.

Jie Yang, Haiyang Meng, Duolu Li, Yanying Wang, Zhaosen Gu, Xiaojian Zhang. Drug-related problems among inpatients of integrated traditional Chinese and western medicine department in China[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(4): 279-288.

图/表 4

Figure 1. Overview of study procedure.

Table 1. Proportions of drug categories that were most frequently implicated causing DRPs.

Table 2. Distribution of DRP groups according to the PCNE-DRP V9.0.

Table 3. Correlation analysis of DRP performance and potential influencing factors.

参考文献 30

[1]	Wang, J.; Wong, Y.K.; Liao, F. What has traditional Chinese medicine delivered for modern medicine? Expert. Rev. Mol. Med. 2018, 20, e4.
[2]	Chan, K.W.; Wong, V.T.; Tang, S.C.W. COVID-19: an update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-western medicine for the management of 2019 novel coronavirus disease. Am. J. Chin. Med. 2020, 48, 737–762.
[3]	Liu, M.; Gao, Y.; Yuan, Y.; Yang, K.L.; Shi, S.Z.; Zhang, J.H.; Tian, J.H. Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol. Res. 2020, 158, 104896.
[4]	Zhang, J.H.; Wu, M.S.; Wang, Y.F.; Jia, Y.M.; Li, E. Medicine in future and advantages of integrated Chinese and western medicine. Chin. J. Integr. Med. 2019, 25, 87–90.
[5]	World Health Organization. WHO Traditional Medicine Strategy 2014–2023, 2013, 1–78. This article can be found online at https://www.who.int/publications/i/item/ 9789241506096.
[6]	Chan, K.; Zhang, H.W.; Lin, Z.X. An overview on adverse drug reactions to traditional Chinese medicines. Br. J. Clin. Pharmacol. 2015, 80, 834–843.
[7]	Chen, K.C.; Lu, R.; Iqbal, U.; Hsu, K.C.; Chen, B.L.; Nguyen, P.A.; Yang, H.C.; Huang, C.W.; Li, Y.C.; Jian, W.S.; Tsai, S.H. Interactions between traditional Chinese medicine and western drugs in Taiwan: a population-based study. Comput. Methods Programs Biomed. 2015, 122, 462–470.
[8]	Pharmaceutical Care Network Europe Foundation. PCNE Classification for Drug Related Problems Version 9.0, 2019, 1–19. This article can be found online at https://www.pcne.org/upload/files/333_PCNEV9.0_ Chinese_Translation_Mandarin.pdf.
[9]	Li, Q.; Qu, H.J.; Lv, D.; Yeh, M.K.; Sun, S.S.; Li, L.; Liao, Y. Drug-related problems among hospitalized patients with COPD in mainland China. Int. J. Clin. Pharm. 2019, 41, 1507–1515.
[10]	Zaman Huri, H.; Chai Ling, L. Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. BMC Public Health. 2013, 13, 1192.
[11]	Zaman Huri, H.; Hui Xin, C.; Sulaiman, C.Z. Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study. PLoS One. 2014, 9, e86215.
[12]	Chan, D.C.; Chen, J.H.; Kuo, H.K.; We, C.J.; Lu, I.S.; Chiu, L.S.; Wu, S.C. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch. Gerontol. Geriatr. 2012, 54, 168–174.
[13]	Somers, A.; Robays, H.; Vander Stichele, R.; Maele, G.; Bogaert, M.; Petrovic, M. Contribution of drug related problems to hospital admission in the elderly. J. Nutr. Health Aging. 2010, 14, 477–482.
[14]	Hsu, W.T.; Shen, L.J.; Lee, C.M. Drug-related problems vary with medication category and treatment duration in Taiwanese heart failure outpatients receiving case management. J. Formos. Med. Assoc. 2016, 115, 335–342.
[15]	Schindler, E.; Richling, I.; Rose, O. Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation. Int. J. Clin. Pharm. 2021, 43, 726–730.
[16]	van Mil, J.W.; Westerlund, L.O.; Hersberger, K.E.; Schaefer, M.A. Drug-related problem classification systems. Ann. Pharmacother. 2004, 38, 859–867.
[17]	Nightingale, G.; Hajjar, E.; Swartz, K.; Andrel-Sendecki, J.; Chapman, A. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J. Clin. Oncol. 2015, 33, 1453–1459.
[18]	Suich, R.C.; Turek, R.J. An asymptotic partial correlation test for the Goodman-Kruskal lambda. Br. J. Math. Stat. Psychol. 2003, 56, 111–117.
[19]	Puumalainen, E.; Airaksinen, M.; Jalava, S.E.; Chen, T.F.; Dimitrow, M. Comparison of drug-related problem risk assessment tools for older adults: a systematic review. Eur. J. Clin. Pharmacol. 2020, 76, 337–348.
[20]	Kara, E.; İnkaya AÇ, Aydın Haklı, D.; Demirkan, K.; Ünal, S. Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience. Turkish J. Med. Sci. 2019, 49, 222–229.
[21]	Stafford, L.; Stafford, A.; Hughes, J.; Angley, M.; Bereznicki, L.; Peterson, G. Drug-related problems identified in post-discharge medication reviews for patients taking warfarin. Int. J. Clin. Pharm. 2011, 33, 621–626.
[22]	Zhu, Y.L.; Liu, C.; Zhang, Y.; Shi, Q.P.; Kong, Y.Q.; Wang, M.Q.; Xia, X.M.; Zhang, F. Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China. Int. J. Clin. Pharm. 2019, 41, 1570–1577.
[23]	Dharmarajan, T.S. The use and misuse of proton pump inhibitors: an opportunity for deprescribing. J. Am. Med. Dir. Assoc. 2021, 22, 15–22.
[24]	Luo, H.L.; Fan, Q.Z.; Bian, T.R.; Li, X.Y.; Chen, K.; Zhang, Q.B.; Wei, Y.T.; Xiao, Y.; Li, Y. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China. BMC Health Serv. Res. 2019, 19, 1–9.
[25]	Jiang, Q.; Yu, B.N.; Ying, G.; Liao, J.; Gan, H.; Blanchard, J.; Zhang, J. Outpatient prescription practices in rural township health centers in Sichuan Province, China. BMC Health Serv. Res. 2012, 12, 324.
[26]	Mao, W.; Vu, H.; Xie, Z.; Chen, W.; Tang, S. Systematic review on irrational use of medicines in China and Vietnam. PLoS One. 2015, 10, e0117710.
[27]	Chaudhuri, S.; Pradhan, R. Re-examining the notion of irrational antimicrobial prescribing in LMICs. Lancet Infect. Dis. 2021, 21, 28–29.
[28]	Li, H.N.; Wang, S.W.; Yue, Z.H.; Ren, X.Q.; Xia, J.L. Traditional Chinese herbal injection: Current status and future perspectives. Fitoterapia. 2018, 129, 249–256.
[29]	Li, X.T.; Thai, S.; Lu, W.C.; Sun, S.S.; Tang, H.L.; Zhai, S.D.; Wang, T.S. Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database. Int. J. Clin. Pharm. 2018, 40, 921–927.
[30]	Li, H.N.; Deng, J.X.; Deng, L.W.; Ren, X.Q.; Xia, J.L. Safety profile of traditional Chinese herbal injection: an analysis of a spontaneous reporting system in China. Pharmacoepidemiol. Drug Saf. 2019, 28, 1002–1013.

国内中西医结合病房的药物治疗相关问题研究

Drug-related problems among inpatients of integrated traditional Chinese and western medicine department in China

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 4

参考文献 30

相关文章 0

编辑推荐

Metrics

本文评价